{"id":{"repo_id":"csusb","oai_identifier":"oai:scholarworks.lib.csusb.edu:etd-project-3009"},"canonical_url":"https://search.ndltd.org/etd/csusb/oai:scholarworks.lib.csusb.edu:etd-project-3009","repository":{"repo_id":"csusb","name":"CSUniversity San Bernardino","base_url":"https://scholarworks.lib.csusb.edu/do/oai/"},"display":{"title":"The effects of R-flurbiprofen in reducing tumors in a multiple intestinal neoplasia mouse model","abstract":"The design of the proposed study was to administer R-FB to 72-day old Min/+ mice for up to 42 days. In order to capture the process of tumor reduction, animals were necropsied at various time points. At each time point animals were evaluated for tumor loads and presence of apoptotic cells along the small intestine. Studies have shown that when R-flurbiprofen (R-FB) is administered in the Min/+ mouse model it can cause the prevention and regression on intestinal tumors.","abstract_html":"The design of the proposed study was to administer R-FB to 72-day old Min/+ mice for up to 42 days. In order to capture the process of tumor reduction, animals were necropsied at various time points. At each time point animals were evaluated for tumor loads and presence of apoptotic cells along the small intestine. Studies have shown that when R-flurbiprofen (R-FB) is administered in the Min/+ mouse model it can cause the prevention and regression on intestinal tumors.","abstract_has_math":false,"creators":["Quiggle, David Douglas"],"institution":null,"degree_name":"Master of Science in Biology","degree_level":"Thesis","degree_discipline":"Biology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T08:05:40Z","subjects":["Cancer -- Research","Flurbiprofen","Tumors -- Animal models","Animal models in research","Medicine","Experimental","Intestines -- Tumors","Tumors in animals","Experiential research","Apoptosis","Cancer Biology"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://scholarworks.lib.csusb.edu/etd-project/2009","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://scholarworks.lib.csusb.edu/etd-project/2009","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://scholarworks.lib.csusb.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Ascholarworks.lib.csusb.edu%3Aetd-project-3009","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Quiggle, David Douglas"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.created","label":"Dc Date Created","values":["2001-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science in Biology"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Cancer -- Research","Flurbiprofen","Tumors -- Animal models","Animal models in research","Medicine","Experimental","Intestines -- Tumors","Tumors in animals","Experiential research","Apoptosis","Cancer Biology"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://scholarworks.lib.csusb.edu/etd-project/2009"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The design of the proposed study was to administer R-FB to 72-day old Min/+ mice for up to 42 days. In order to capture the process of tumor reduction, animals were necropsied at various time points. At each time point animals were evaluated for tumor loads and presence of apoptotic cells along the small intestine. Studies have shown that when R-flurbiprofen (R-FB) is administered in the Min/+ mouse model it can cause the prevention and regression on intestinal tumors."]},{"key":"dc:title","label":"Title","values":["The effects of R-flurbiprofen in reducing tumors in a multiple intestinal neoplasia mouse model"]}]}],"canonical_facts":{"dc:creator":["Quiggle, David Douglas"],"dc:date.created":["2001-01-01T08:00:00Z"],"dc:description.abstract":["The design of the proposed study was to administer R-FB to 72-day old Min/+ mice for up to 42 days. In order to capture the process of tumor reduction, animals were necropsied at various time points. At each time point animals were evaluated for tumor loads and presence of apoptotic cells along the small intestine. Studies have shown that when R-flurbiprofen (R-FB) is administered in the Min/+ mouse model it can cause the prevention and regression on intestinal tumors."],"dc:identifier":["https://scholarworks.lib.csusb.edu/etd-project/2009"],"dc:subject":["Cancer -- Research","Flurbiprofen","Tumors -- Animal models","Animal models in research","Medicine","Experimental","Intestines -- Tumors","Tumors in animals","Experiential research","Apoptosis","Cancer Biology"],"dc:title":["The effects of R-flurbiprofen in reducing tumors in a multiple intestinal neoplasia mouse model"],"thesis:degree_discipline":["Biology"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Master of Science in Biology"]},"updated_at":"2026-11-19T08:05:40Z"}